Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 117.05
-1.41 %
$ 11.7 B
Market Cap
35.58
P/E
NBIX - OPERATING EXPENSES
Operating Expenses NBIX - Neurocrine Biosciences, Inc.
1.75 B
LAST VALUE
19.97%
2 YEAR CAGR
25.87%
5 YEAR CAGR
39.13%
10 YEAR CAGR